Opinion: The ethics of pausing a vaccine trial in the midst of a pandemic: a conversation with Ruth Faden
The revelation that AstraZeneca paused its clinical trials for a Covid-19 vaccine has focused attention on the company and the clinical trial process.
The hold occurred after a participant in the trial developed symptoms consistent with a rare but serious spinal inflammatory disorder called transverse myelitis.
